OQROGet OQRO Pro
Insider trade

Metagenomi Therapeutics (MGX)See Remarks sold ~$360

Matthew Wein, See Remarks at Metagenomi Therapeutics, sold ~$360 of Metagenomi Therapeutics shares.

~$360
Approx. value · 199 sh @ $1.81
19K
Holds after · shares reported
Traded
Sep 5, 2025
Filed
Dec 1, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 5, 2025 · this disclosureInsiderOfficer sold ~$360 of MGX shares in the open market

What came next

  1. Sep 5, 2025Insider · 3 peopleInsiders: 3 sales (~$11K)
  2. Sep 29, 2025Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement
  3. Nov 11, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  4. Dec 5, 2025Insider · 4 peopleInsiders: 4 sales (~$13K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Metagenomi Therapeutics

For Metagenomi Therapeutics, OQRO holds 5 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MGX page.

Other recent filings by Matthew Wein, See Remarks

The full history of Matthew Wein, See Remarks is on the profile page.

How this filing works

Other disclosures at Metagenomi Therapeutics

Everything OQRO holds on this company is on its MGX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data